Autoimmune hemolytic anemia (AIHA) is a rare but potentially serious blood disorder in which the immune system mistakenly attacks and destroys red blood cells, leading to anemia and a range of associated complications. Managing AIHA requires a nuanced approach tailored to the severity of hemolysis, underlying causes, and patient-specific factors. Recent advances in treatment strategies have...